An exploratory study on the usefulness of topical benzoxyl peroxide for prolonged acneiform eruption by EGFR inhibitors
- Conditions
- acneiform eruption
- Registration Number
- JPRN-UMIN000032280
- Lead Sponsor
- Tohoku University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Not provided
(1)Oral tetracycle (MINO or DOXY) has been started within 4 weeks for the treatment of acneiform eruption. (2)Oral steroids are administrated for the treatment of acneiform eruption. (3)Patient has skin lesion of skin metastatic lesions, burns, frostbite, trauma, scars and/or other lesions to be difficult to evaluate skin symptoms on the test area. (4)Patient has erosions, wounds, etc. that are problematic in applying benzoyl peroxide: BPO gel to the test area. (5)Patient has a history of hypersensitivity to BPO. (6)Pregnant women, women who has possibility of pregnant, woman within 28 days after childbirth, or woman who in breastfeeding. (7)Patient who is considered to have difficulty participating in research by merging psychosis or psychiatric symptoms. (8)Patient who researchers deem that research participation is inappropriate.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity grade of acneiform eruption on the face before and 8 weeks after the test treatment
- Secondary Outcome Measures
Name Time Method